Addressing 4 Common Roadblocks When Using RWD in Regulatory SubmissionsByScott Swain, PhD, MPHJanuary 18th 2022Scott Swain details the most common roadblocks that pharma companies experience when incorporating real-world data (RWD) in regulatory submissions and looks at how they can be addressed.